Page 92 - Amgen News Today

Essex Savings Bank decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,393 shares of the medical research company’s stock after selling 189 shares during the period. Essex […]

Essex Savings Bank cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,393 shares of the medical research company’s stock after selling 189 shares during the quarter. Essex Savings […]

Biosimilar approved; clinical trial data supports early intensive therapy

Mayflower Financial Advisors LLC cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,781 shares of the medical research company’s stock after selling 79 shares during the quarter. Mayflower Financial Advisors […]

Plus: Senior living company Edgemere names new executive director, McCarthy Building Cos. adds pair of VPs, and more.

Silverlake Wealth Management LLC lessened its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 4,960 shares of the medical research company’s stock after selling 1,181 shares during the quarter. Amgen makes up 0.8% of Silverlake Wealth Management LLC’s holdings, making the stock its […]

Silverlake Wealth Management LLC lessened its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,960 shares of the medical research company’s stock after selling 1,181 shares during the quarter. Amgen […]

Fusion Capital LLC raised its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,697 shares of the medical research company’s stock after purchasing an additional 289 shares during the quarter. Amgen accounts […]

Fulcrum Equity Management decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.1% in the 4th quarter, Holdings Channel reports. The fund owned 1,859 shares of the medical research company’s stock after selling 142 shares during the quarter. Fulcrum Equity Management’s holdings in Amgen were worth $535,000 as of its most […]

Fifth Third Bancorp increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 334,053 shares of the medical research company’s stock after buying an additional 3,953 shares during the quarter. Fifth […]